FHTX – foghorn therapeutics inc. (US:NASDAQ)

News

Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at Wall Stre
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
4D Molecular Therapeutics taps Kristian Humer as CFO [Seeking Alpha]
4DMT Appoints Kristian Humer as Chief Financial Officer [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com